Saturday 17 October 2026 Export GNTA’s income statement to Excel — free account

Genenta Science S.p.A. Unsponsored ADR

GNTA Healthcare Biotechnology

0.68 0.01 +1.49%

Follow GNTA

Alert me

Market cap: $32.3M
P/E: —
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Jun '24	Dec '24	Jun '25	Dec '25
ROE Full definition →	+7 more TTM periods Free account	0.00%	0.00%	0.00%	0.00%
ROA Full definition →		0.00%	0.00%	0.00%	0.00%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Average Days of Receivables Full definition →		—	—	—	—
Free Cash Flow per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow Full definition →		(30.48)	(29.40)	(27.39)	(23.02)
Capital Expenditures Full definition →		(0.06)	(0.04)	(0.03)	(0.02)
Other line items
Cash ROIC Full definition →		(83.94%)	(107.99%)	(64.61%)	(35.33%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		0.00%	—	0.00%	—
Operating CF/Net income Full definition →		0.00	0.00	0.00	0.00
Depreciation/Fixed assets Full definition →		0.67	0.92	3.21	0.71
Capex/Depreciation Full definition →		(0.59)	(0.25)	(0.23)	(0.20)
Operating CF per Share Full definition →		0.00	0.00	0.00	0.00
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates